Login to Your Account

BIO 2011 International Convention

Commercial Era for Biotech? Plan Early, Often, Experts Say

By Jennifer Boggs

Tuesday, June 28, 2011
WASHINGTON – Amid the usual sessions on finance, business development and biomarkers, a fledgling emerging leaders workshop met Monday at BIO 2011 International Convention to discuss commercialization, an activity that has become a bigger focus for biotech, as the industry matures and as policy makers put increasing pressure on reimbursement and differentiation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription